Literature DB >> 14504095

Interleukin-18 attracts plasmacytoid dendritic cells (DC2s) and promotes Th1 induction by DC2s through IL-18 receptor expression.

Arthur Kaser1, Susanne Kaser, Nicole C Kaneider, Barbara Enrich, Christian J Wiedermann, Herbert Tilg.   

Abstract

In vivo evidence suggests that interleukin-18 (IL-18) shapes the development of adaptive immunity toward T-helper cell type 1 (Th1) responses. Monocyte-derived dendritic cells 1 (DC1s) preferentially induce a Th1 response, while plasmacytoid DC-derived DC2s have been linked to a Th2 response. We analyzed the role of IL-18 during the initiation phase of a Th response in vitro to elucidate the basis of these in vivo observations. IL-18 was constitutively released from DC1s, but not DC2s. Neutralization of IL-18 in coculture experiments of DC1s with allogeneic naive T lymphocytes did not alter the Th1/Th2 phenotype, while anti-IL-12 efficiently down-regulated the Th1 response. Unexpectedly, IL-18 receptor (IL-18R) alpha and beta chains were expressed on DC2 lineage. IL-18R expression was functional, as IL-18 induced chemotaxis in plasmacytoid DCs (pre-DC2s) and enhanced the allostimulatory capacity of IL-3-differentiated DC2s. Pre-DC2s exposed to IL-18 skewed the development of Th cells toward Th1 in coculture experiments of DC2s and allogeneic naive T cells, which was inhibited by IL-12 p70 neutralization. IL-18 might have a profound role during the initiation phase of an immune response by recruiting pre-DC2s and modulating the function of DC2s.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14504095     DOI: 10.1182/blood-2002-07-2322

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

Review 1.  Plasmacytoid dendritic cells: linking innate and adaptive immunity.

Authors:  Kelli McKenna; Anne-Sophie Beignon; Nina Bhardwaj
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 2.  Lupus nephritis: the evolving role of novel therapeutics.

Authors:  Brad H Rovin; Samir V Parikh
Journal:  Am J Kidney Dis       Date:  2014-01-07       Impact factor: 8.860

Review 3.  Chemokine and chemotactic signals in dendritic cell migration.

Authors:  Laura Tiberio; Annalisa Del Prete; Tiziana Schioppa; Francesca Sozio; Daniela Bosisio; Silvano Sozzani
Journal:  Cell Mol Immunol       Date:  2018-03-21       Impact factor: 11.530

Review 4.  Plasmacytoid dendritic cells in HIV infection.

Authors:  Meagan O'Brien; Olivier Manches; Nina Bhardwaj
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

5.  Interleukin-18 overexpression as a hallmark of the activity of autoimmune inflammatory myopathies.

Authors:  M Tucci; C Quatraro; F Dammacco; F Silvestris
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

Review 6.  New approaches to the development of adenoviral dendritic cell vaccines in melanoma.

Authors:  Lisa H Butterfield; Lazar Vujanovic
Journal:  Curr Opin Investig Drugs       Date:  2010-12

7.  Enhanced viral clearance in interleukin-18 gene-deficient mice after pulmonary infection with influenza A virus.

Authors:  Koenraad F Van Der Sluijs; Leontine J R Van Elden; Ramon Arens; Monique Nijhuis; Rob Schuurman; Sandrine Florquin; Joan Kwakkel; Shizuo Akira; Henk M Jansen; René Lutter; Tom Van Der Polls
Journal:  Immunology       Date:  2005-01       Impact factor: 7.397

Review 8.  Cytokine overproduction, T-cell activation, and defective T-regulatory functions promote nephritis in systemic lupus erythematosus.

Authors:  Marco Tucci; Stefania Stucci; Sabino Strippoli; Francesco Silvestris
Journal:  J Biomed Biotechnol       Date:  2010-06-29

9.  Rheumatoid arthritis synovium contains two subsets of CD83-DC-LAMP- dendritic cells with distinct cytokine profiles.

Authors:  M Cristina Lebre; Sarah L Jongbloed; Sander W Tas; Tom J M Smeets; Iain B McInnes; Paul P Tak
Journal:  Am J Pathol       Date:  2008-02-21       Impact factor: 4.307

Review 10.  Cellular targets of interleukin-18 in rheumatoid arthritis.

Authors:  Sheng-Ming Dai; Zheng-Zheng Shan; Huji Xu; Kusuki Nishioka
Journal:  Ann Rheum Dis       Date:  2007-05-14       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.